normalax
taro pharmaceutical industries ltd - polyethylene glycol 3350 - powder for solution - polyethylene glycol 3350 100 %w/w - osmotically acting laxatives - for the treatment of constipation.
impavido 10 mg
megapharm ltd - miltefosine - hard capsule - miltefosine 10 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.
impavido 50 mg
megapharm ltd - miltefosine - hard capsule - miltefosine 50 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.
ritalin 10 mg tablets
novartis israel ltd - methylphenidate hydrochloride - tablets - methylphenidate hydrochloride 10 mg - methylphenidate - methylphenidate - attention deficit hyperactivity disorder (adhd). narcolepsy.
ritalin sr 20 mg tablets
novartis israel ltd - methylphenidate hydrochloride - tablets - methylphenidate hydrochloride 20 mg - methylphenidate - attention deficit hyperactivity disorders . narcolepsy.
ritalin la 10 mg modified-release capsules
novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 10 mg - methylphenidate - attention deficit hyperactivity disorder (adhd) .
ritalin la 20 mg modified-release capsules
novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 20 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).
ritalin la 30 mg modified-release capsules
novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 30 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).
ritalin la 40 mg modified-release capsules
novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 40 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).
maxibone 70
unipharm ltd, israel - alendronate as sodium - tablets - alendronate as sodium 70 mg - alendronic acid - maxibone is indicated for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures).treatment to increase bone mass in men with osteoporosis.